[1] |
Zhang Chao, Yu Xia, Huang Hairong, Liu Wei, Liu Tao.
Evaluation of the in vitro antimicrobial effects of sevoflurane on Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(2): 158-163.
|
[2] |
Pan Meimin, Li Wenjuan, Zhang Xuehong, Yang Lihui, He Juan, Tan Yongwei.
Study on serum TNFSF14 and sIL-2R levels in elderly patients with pulmonary tuberculosis and their correlation with short-term prognosis
[J]. Chinese Journal of Antituberculosis, 2025, 47(1): 66-71.
|
[3] |
Tian Hongjing, Zhang Yanjun, Deng Qiang, Li Junjie, Yang Jun, Liu Xinfeng, Du Jianqiang.
Research progress on osteoclasts activated by receptor activator of nuclear factor-κB ligand signaling pathway for the treatment of bone tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(8): 971-975.
|
[4] |
Han Wenya, Zhou Yangyu, Wang Meifang, Xue Xinying.
Progress in clinical diagnosis and treatment of pulmonary cryptococcosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 830-838.
|
[5] |
Liu Haohan, Ma Zichun, Pang Yu, Li Shanshan.
The function and mechanism of G protein-coupled receptors in host against Mycobacterium tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2024, 46(7): 839-844.
|
[6] |
Shang Xuetian, Dong Jing, Huang Mailing, Sun Qi, Jia Hongyan, Zhang Lanyue, Liu Qiuyue, Yao Mingxu, Wang Yingchao, Ji Xiuxiu, Du Boping, Xing Aiying, Pan Liping.
Transcriptome study on peripheral blood mononuclear cells of latent tuberculosis infection individuals
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 449-460.
|
[7] |
Zheng Hailun, Li Yamin, Sun Shanhua, He Xiaoxin.
Analysis of influencing factors on treatment interruption in 317 pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 467-472.
|
[8] |
Chen Feifei, Zheng Yongzhi, Wu Sufang, Kang Qian, Jin Chunyang.
Regulating effect of reactive oxygen species/protein kinase RNA-like endoplasmic reticulum kinase signaling axis on BCG-induced ferroptosis in mouse macrophages
[J]. Chinese Journal of Antituberculosis, 2024, 46(12): 1448-1458.
|
[9] |
Ye Jiang’e, Fang Xuehui, Xiong Yanjun, Liu Shengsheng.
Transcriptomics and machine learning algorithm-based characterization of ferroptosis-related genes in tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 92-99.
|
[10] |
Zhao Yong, Liang Lili, Jiang Nan.
Impact of targeted regulation of miR-144-3p by LncRNA GAS5 on macrophage apoptosis and inflammatory response in Mycobacterium tuberculosis infected macrophages
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 744-751.
|
[11] |
Huang Jinpeng, Chen Yuanyuan, Gao Dan, Mao Xiaoxiao, Zhang Yue, Gao Jing.
The effect of programmed emergency nursing in patients of pulmonary tuberculosis with massive hemoptysis
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 768-774.
|
[12] |
Bei Cheng, Li Meng, Gao Qian.
Research progress on blood transcriptomic biomarkers in the diagnosis of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 801-807.
|
[13] |
Wang Wenjing, Sun Hong, Sun Zhaogang.
Progress of innate immune mechanism activated by Mycobacterium tuberculosis DNA-mediated pattern recognition receptors
[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 426-433.
|
[14] |
Peng Jiangli, Chen Jie, Chen Yonggang, Wang Lu, Li Na, Luo Ji, Han Yi, Yu Mingli, Zhu Jiangchun.
SLC22A12 gene polymorphism study on susceptibility to hyperuricemia induced by pyrazinamide
[J]. Chinese Journal of Antituberculosis, 2023, 45(2): 151-158.
|
[15] |
Duan Shujuan, Zhao Lingjuan, Li Chuanyou, Li Ling, Wang Wei.
Association of ESRRB rs12437118 polymorphisms with tuberculosis susceptibility of Han population in northern China
[J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1152-1157.
|